Standard BioTools (LAB) and SomaLogic (SLGC) to Combine in All-Stock Merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools
October 4, 2023 8:00 AM EDTActivates Standard BioTools strategy to unlock value in underserved portion of $100 billion industry
Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights
Expands commercial reach with substantial cross-selling opportunities and complementary offerings
Generates estimated $80 million of annual cost synergies by 2026 and enhanced combined path to profitability1
Estimated combined cash of over $500 million at close2 creates industry-leading balance sheet to fund growth initiatives
Standard BioTools increases... More
